Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
3.145
+0.045 (1.44%)
Dec 31, 2024, 9:59 AM EST - Market open
Tango Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 338 | 1,010 | 639 | 958 | - | - |
| Market Cap Growth | -27.98% | 57.94% | -33.25% | - | - | - |
| Enterprise Value | 77 | 689 | 287 | 461 | - | - |
| Last Close Price | 3.10 | 9.90 | 7.25 | 10.94 | 11.44 | - |
| PS Ratio | 7.71 | 27.64 | 25.72 | 25.86 | - | - |
| PB Ratio | 1.45 | 3.99 | 2.56 | 2.78 | - | - |
| P/TBV Ratio | 3.60 | 3.99 | 2.56 | 2.78 | - | - |
| EV/Sales Ratio | 1.78 | 18.87 | 11.53 | 12.45 | - | - |
| Debt / Equity Ratio | 0.16 | 0.15 | 0.16 | 0.00 | 0.20 | 1.08 |
| Debt / FCF Ratio | - | - | - | - | 0.11 | - |
| Asset Turnover | 0.11 | 0.09 | 0.05 | 0.10 | 0.06 | - |
| Quick Ratio | 7.80 | 7.33 | 6.63 | 11.97 | 4.70 | 1.56 |
| Current Ratio | 8.00 | 7.54 | 6.76 | 12.10 | 4.73 | 1.61 |
| Return on Equity (ROE) | -48.80% | -40.49% | -36.41% | -30.38% | -223.51% | - |
| Return on Assets (ROA) | -22.37% | -17.01% | -14.82% | -10.28% | -24.81% | - |
| Return on Capital (ROIC) | -29.96% | -24.49% | -21.80% | -18.52% | -103.69% | - |
| Earnings Yield | -37.06% | -10.08% | -16.92% | -6.08% | - | - |
| FCF Yield | -36.99% | -11.84% | -18.27% | -6.41% | - | - |
| Buyback Yield / Dilution | -19.36% | -7.69% | -41.40% | -94.50% | -255.37% | - |
| Total Shareholder Return | -19.36% | -7.69% | -41.40% | -94.50% | -255.37% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.